Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
J Ovarian Res. 2021 Oct 13;14(1):132. doi: 10.1186/s13048-021-00887-w.
Sentinel lymph node (SLN) detection in ovarian cancer is feasible when tracers are injected before the pathological ovary is resected. This study aims to investigate whether the SLN identification is also feasible in patients whose ovarian tumor has already been resected with injection of the tracer into the ovarian ligaments stumps, i.e. in the event that a frozen section confirms malignancy.
Patients who underwent laparotomy with frozen section confirming an ovarian malignancy, and those who underwent a second staging laparotomy after prior resection of a malignant ovarian mass, were included. Blue dye and a radioactive isotope were injected in the stumps of the ligamentum ovarium proprium and the ligamentum infundibulo-pelvicum. After an interval of at least 15-min, the sentinel node(s) were identified using either the gamma-probe and / or blue dye.
A total of 11 patients were included in the study, the sentinel node (SLN) procedure was completed in all 11 patients. At least one SLN was identified in 3 patients, resulting in a rather low detection rate of 27,3%.
In this study we showed that SLN procedure after (previous) resection of the tumor seems inferior to detect sentinel nodes when compared to injection of the tracer in the ovarian ligaments before tumor resection.
NCT02540551.
在切除病理性卵巢前注射示踪剂,卵巢癌前哨淋巴结(SLN)检测是可行的。本研究旨在探讨在已经切除卵巢肿瘤并将示踪剂注射到卵巢韧带残端的患者中,即冷冻切片证实为恶性时,SLN 识别是否也是可行的。
纳入接受剖腹手术且冷冻切片证实为卵巢恶性肿瘤的患者,以及先前切除恶性卵巢肿块后接受二次分期剖腹手术的患者。在卵巢固有韧带和漏斗骨盆韧带残端注射蓝色染料和放射性同位素。间隔至少 15 分钟后,使用伽马探针和/或蓝色染料识别前哨淋巴结(SLN)。
共有 11 名患者纳入本研究,11 名患者均完成了 SLN 手术。3 名患者至少识别出 1 个 SLN,检出率仅为 27.3%。
与肿瘤切除前在卵巢韧带中注射示踪剂相比,本研究显示,肿瘤切除后的 SLN 操作似乎难以检测到前哨淋巴结。
NCT02540551。